OBA-PHARMA ApS: Financial statements 2021
CVR: 19995607
Source: annual report 2021, Danish Business Authority
01/10/2020 – 30/09/2021
OBA-PHARMA ApS (CVR 19995607) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 1,333,640 and a net result of DKK 1,001,773 compared with DKK 865,029 the year before. That is an increase of 19.1% compared with the year before. Equity in the 2021 report amounted to DKK 2,168,885. The solvency ratio was 44.4%.
- Gross Profit
- DKK 1,333,640
- Profit/Loss
- DKK 1,001,773
- Equity
- DKK 2,168,885
- Total Assets
- DKK 4,888,892
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 1.3 mio. | 1 mio. | 2.2 mio. | 0 |
| 2020 | - | 1.1 mio. | 865 t. | 1.2 mio. | 0 |
| 2019 | - | 2.3 mio. | 1.8 mio. | 2.3 mio. | - |
| 2018 | - | 2.5 mio. | 2.1 mio. | 6.5 mio. | - |
| 2017 | - | 2.8 mio. | 2.2 mio. | 4.4 mio. | - |
Official annual report
Find more companies like OBA-PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
OBA-PHARMA ApS has published its annual report for 2020. Gross profit came to DKK 1,119,532, and the net result was DKK 865,029.
About OBA-PHARMA ApS
OBA-PHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 1997. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named PBH 25.376 ApS. The management consists of Malene Dybdahl Birch. The company is owned by LEV-VEL ApS and NLDB Holding ApS. The company has 0 employees (2000). In 2024, the company reported a gross profit of DKK 3,402,201 and a net result of DKK 2,670,973 compared with DKK 2,073,440 the year before. Equity in the 2024 report amounted to DKK 674,251.